CCOC(=O)c1[nH]c(C)c(CCC(=O)N2CCN(c3cccc(OC)c3)CC2)c1C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?